Bellicum Pharmaceuticals

173 articles about Bellicum Pharmaceuticals

• Bellicum Licenses TCR Technology From Leiden University Medical Center

  4/30/2015

• Bellicum Provides Operational Update And Reports Financial Results For Fourth Quarter And Year Ended December 31, 2014

  3/12/2015

• Bellicum To Report Fourth Quarter And Full Year 2014 Financial Results On March 11, 2015

  3/4/2015

• Fresh Off Its $140 Million IPO, Bellicum Lays Out Hiring Plans

  2/27/2015

• Bellicum Pharmaceuticals, Inc. To Present At The 2015 Leerink Global Healthcare Conference

  2/4/2015

• Bellicum Pharmaceuticals, Inc. Announces Successful Dosing Of First Patient Cohort With BPX-501 T Cells Following Haplo-Identical Hematopoietic Stem Cell Transplant

  1/13/2015

• Bellicum Pharmaceuticals, Inc. Announces Closing Of Initial Public Offering And Exercise Of The Underwriters’ Option

  12/24/2014

• Nasdaq Welcomes Bellicum Pharmaceuticals, Inc. To The Nasdaq Stock Market

  12/19/2014

• Bellicum Pharmaceuticals, Inc. Prices Initial Public Offering Of 7,350,000 Shares Of Common Stock

  12/18/2014

• Houston-Based Bellicum Pharmaceuticals, Inc. Sets Terms For $100 Million IPO

  12/12/2014

• Bellicum Pharmaceuticals, Inc. Announces New Director, Executive Management Appointments

  12/5/2014

• Cancer Biotech Bellicum Pharmaceuticals, Inc. Files For $115 Million IPO

  11/19/2014

• Bellicum Pharmaceuticals, Inc. Appoints Reid Huber, Ph.D. To Board Of Directors

  11/17/2014

• Ariad Pharmaceuticals, Inc., Bellicum Pharmaceuticals, Inc. Revise Pact; Ariad Will Receive $50 Million In Three Installments

  10/6/2014

• Houston Biotech Bellicum Pharmaceuticals, Inc. Nabs $55 Million

  8/27/2014

• Bellicum Pharmaceuticals, Inc. To Present At Jefferies and Co. 2014 Global Healthcare Conference In New York City

  6/3/2014

• Bellicum Pharmaceuticals, Inc. To Present At Jefferies and Co. 2014 Global Healthcare Conference In New York City

  6/3/2014

• Bellicum Pharmaceuticals, Inc. Hauls In $34.4 Million Series B Financing

  1/7/2014

• Bellicum Pharmaceuticals, Inc. Initiates Clinical Trial With Novel Controlled Dendritic Cell Immunotherapy in Metastatic Castrate Resistant Prostate Cancer

  7/9/2013

• Bellicum Pharmaceuticals, Inc. Selects DATATRAK International, Inc. Solution for Drug Program

  9/12/2012